{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T23:29:14Z","timestamp":1786663754354,"version":"build-2736575974"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":85,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004513","name":"Harry Crossley Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004513","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Clinical lupus myocarditis (LM) occurs in 5\u201310% of systemic lupus erythematosus (SLE) patients while sub-clinical presenting in approximately 40%. To date, an in-depth cytokine profile of cardiac tissue is lacking, yet vital to understanding disease mechanisms. This study aimed to correlate cardiac tissue inflammatory profile to standard of care (SOC) parameters (serum biomarkers and cardiac MRI (CMR)) in an African mixed-ancestry LM population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      One control (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20096) and two SLE cohorts, SLE (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200913) and SLE with myocarditis (SLE-M;\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200914) were recruited. Serum cytokines were assessed using immunoassays. SLE patients underwent SOC clinical assessments (serology, CMR) and endomyocardial biopsy (EMB, LM only). EMB tissue was immunostained for inflammation, fibrosis and tissue damage.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Systemic inflammation in LM was confirmed with increased serum (s) sTNF-\u03b1 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05), sIL-18 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05), sIL-6 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01), sIL-10 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01) and sVCAM-1 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Higher sIL-10 (associated with disease activity) and sVCAM-1 (endothelial activation) were observed in SLE-M vs. SLE (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01). Matching serum and tissue parameters showed no correlation, suggesting a disconnect between circulation and tissue compartments. Functionally contradictory negative correlations between sTNF-\u03b1, sVCAM-1 and tissue (t) tIL-6 (both\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05) implied a relative lower presence of tIL-6, which would limit conversion from a pro-inflammatory to an anti-inflammatory, reparative state (supported by accompanying low tIL-10). This limited tIL-6 presence was further implicated by negative correlations with CMR inflammation and necrosis\/fibrosis (T1, T2). Anti-Ro\/La correlated to TGF-\u03b2 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05), key in fibrosis development. Fibrosis markers did not correlate with CMR fibrosis suggesting a temporal lag before detectable CMR fibrosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Based on presented exploratory data, we hypothesize that inadequate activation of myocardial IL-6 and IL-10 may impair inflammatory regulation. Data suggest that myocardial pro-fibrotic signaling may be detectable at a time point preceding CMR-detectable fibrosis. Purpose-designed research to test this hypothesis of limited IL-6 presence is required to inform on future therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s10020-026-01504-6","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T08:09:08Z","timestamp":1779350948000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum vs. tissue cytokine dysregulation in SLE-associated myocarditis: a hypothesis from an African cohort perspective"],"prefix":"10.1186","volume":"32","author":[{"given":"Tracey","family":"Ollewagen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riette","family":"du Toit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumanth","family":"Karamchand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton F","family":"Doubell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip G","family":"Herbst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"1504_CR1","doi-asserted-by":"crossref","unstructured":"Apte M, McGwin G, Vil\u00e1 LM, Kaslow RA, Alarc\u00f3n GS, Reveille JD. Associated factors and impact of myocarditis in patients with SLE from LUMINA, a multiethnic US cohort. Rheumatology: Oxford University Press. 2008;47(3):362\u20137.","DOI":"10.1093\/rheumatology\/kem371"},{"issue":"20","key":"1504_CR2","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1016\/j.jacc.2019.08.1061","volume":"74","author":"GD Aquaro","year":"2019","unstructured":"Aquaro GD, Ghebru Habtemicael Y, Camastra G, Monti L, Dellegrottaglie S, Moro C, et al. Prognostic Value of Repeating Cardiac Magnetic Resonance in Patients With Acute Myocarditis. J Am Coll Cardiol Elsevier USA. 2019;74(20):2439\u201348.","journal-title":"J Am Coll Cardiol Elsevier USA"},{"key":"1504_CR3","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1152\/ajpheart.00908.2008","volume":"296","author":"I Banerjee","year":"2009","unstructured":"Banerjee I, Fuseler JW, Intwala AR, Baudino TA. IL-6 loss causes ventricular dysfunction, fibrosis, reduced capillary density, and dramatically alters the cell populations of the developing and adult heart. Am J Physiol Heart Circ Physiol [Internet]. 2009;296:1694\u2013704. Available from: www.ajpheart.org.","journal-title":"Am J Physiol Heart Circ Physiol [Internet]"},{"key":"1504_CR4","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0002-9343(80)80010-6","volume":"69","author":"A Bidani","year":"1980","unstructured":"Bidani A, Roberts J, Schwartz M, Lewis E. Immunopathology of Cardiac Lesions in Fatal Systemic Lupus Erythematosus. Am J Med. 1980;69:849\u201358.","journal-title":"Am J Med"},{"key":"1504_CR5","doi-asserted-by":"crossref","unstructured":"Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O. Oxidative Stress and Antioxidant Defense. World Allergy Organisation J. 2012;5(1):9\u201319.","DOI":"10.1097\/WOX.0b013e3182439613"},{"key":"1504_CR6","first-page":"1","volume":"13","author":"S Biswas","year":"2022","unstructured":"Biswas S, Bieber K, Manz RA. IL-10 revisited in systemic lupus erythematosus. Front Immunol Front Media S A. 2022;13:1\u20136.","journal-title":"Front Immunol Front Media S A"},{"issue":"3","key":"1504_CR7","first-page":"1","volume":"4","author":"M Bose","year":"2022","unstructured":"Bose M, Jefferies C. Sex bias in systemic lupus erythematosus: A molecular insight. Immunometabolism (United States). Lippincott Williams Wilkins. 2022;4(3):1\u20136.","journal-title":"Lippincott Williams Wilkins"},{"issue":"7","key":"1504_CR8","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1002\/acr.20470","volume":"63","author":"J Bourr\u00e9-Tessier","year":"2011","unstructured":"Bourr\u00e9-Tessier J, Clarke AE, Huynh T, Bernatsky S, Joseph L, Belisle P, et al. Prolonged corrected QT interval in anti-Ro\/SSA-positive adults with systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2011;63(7):1031\u20137.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"8","key":"1504_CR9","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1002\/1529-0131(200108)44:8<1832::AID-ART320>3.0.CO;2-C","volume":"44","author":"A Brucato","year":"2001","unstructured":"Brucato A, Frassi M, Franceschini F, Cimaz R, Faden D, Pisoni MP, et al. Risk of congenital complete heart block in newborns of mothers with anti-Ro\/SSA antibodies detected by counterimmunoelectrophoresis: A prospective study of 100 women. Arthritis Rheum. 2001;44(8):1832\u20135.","journal-title":"Arthritis Rheum"},{"key":"1504_CR11","doi-asserted-by":"crossref","unstructured":"Chalaris A, Garbers C, Rabe B, Rose-John S, Scheller J. The soluble Interleukin 6 receptor: Generation and role in inflammation and cancer. Eur J Cell Biol. 2011;90(6\u20137):484\u201394.","DOI":"10.1016\/j.ejcb.2010.10.007"},{"issue":"12","key":"1504_CR12","first-page":"1","volume":"9","author":"DY Chen","year":"2014","unstructured":"Chen DY, Chen YM, Tzang BS, Lan JL, Hsu TC. Th17-related cytokines in systemic lupus erythematosus patients with dilated cardiomyopathies: A possible linkage to parvovirus B19 infection. PLoS One Public Libr Sci. 2014;9(12):1\u201313.","journal-title":"PLoS One Public Libr Sci"},{"key":"1504_CR13","doi-asserted-by":"crossref","unstructured":"Crouch SH, Roux SB, Le, Delles C, Graham LA, Schutte AE. Distinct inflammatory mediator patterns in young black and white adults: The African-predict study. Cytokine: Academic. 2020;126:154894.","DOI":"10.1016\/j.cyto.2019.154894"},{"issue":"13","key":"1504_CR10","doi-asserted-by":"publisher","first-page":"7566","DOI":"10.1074\/jbc.273.13.7566","volume":"273","author":"P De Cesaris","year":"1998","unstructured":"De Cesaris P, Starace D, Riccioli A, Padula F, Filippini A, Ziparo E. Tumor necrosis factor-\u03b1 induces interleukin-6 production and integrin ligand expression by distinct transduction pathways. J Biol Chem. 1998;273(13):7566\u201371.","journal-title":"J Biol Chem"},{"key":"1504_CR14","doi-asserted-by":"publisher","unstructured":"Dhooria A, Gawalkar A, Santosh K, Bahl A, Mb A, Naidu G et al. Acute myocardial dysfunction in lupus: outcomes in Asian Indians. Clin. Rheumatol. 2020;39:3661\u20137. Available from: https:\/\/doi.org\/10.1007\/s10067-020-05177-2.","DOI":"10.1007\/s10067-020-05177-2"},{"key":"1504_CR15","doi-asserted-by":"crossref","unstructured":"Dong C, Wu M, Liu H, Yang K, Ma S, Guo Y, et al. Breaking the cycle: immune complexes, complement activation, and novel immunotherapies in lupus nephritis. Front. Immunol. Frontiers Media SA. 2025;16:1624850.","DOI":"10.3389\/fimmu.2025.1624850"},{"issue":"9","key":"1504_CR16","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1191\/0961203305lu2200oa","volume":"14","author":"A Doria","year":"2005","unstructured":"Doria A, Iaccarino L, Sarzi-Puttini P, Atzeni F, Turriel M, Petri M. Cardiac involvement in systemic lupus erythematosus. Lupus. 2005;14(9):683\u20136.","journal-title":"Lupus"},{"key":"1504_CR17","doi-asserted-by":"crossref","unstructured":"Drazner MH, Bozkurt B, Cooper LT, Aggarwal NR, Basso C, Bhave NM et al. 2024 ACC Expert Consensus Decision Pathway on Strategies and Criteria for the Diagnosis and Management of Myocarditis: A Report of the American College of Cardiology Solution Set Oversight Committee. J. Am. Coll. Cardiol. Elsevier Inc. 2025;85(4):391\u2013431.","DOI":"10.1016\/j.jacc.2024.10.080"},{"issue":"1","key":"1504_CR58","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/0961203316651741","volume":"26","author":"R Du Toit","year":"2017","unstructured":"Du Toit R, Herbst PG, Van Rensburg A, Du Plessis LM, Reuter H, Doubell AF. Clinical features and outcome of lupus myocarditis in the Western Cape, South Africa. Lupus. 2017;26(1):38\u201347.","journal-title":"Lupus"},{"key":"1504_CR60","doi-asserted-by":"crossref","unstructured":"Du Toit R, Reuter H, Walzl G, Snyders C, Chegou NN, Herbst PG, et al. Serum cytokine levels associated with myocardial injury in systemic lupus erythematosus. Rheumatology. 2021;60(4):2010\u201321.","DOI":"10.1093\/rheumatology\/keaa540"},{"key":"1504_CR59","doi-asserted-by":"crossref","unstructured":"du Toit R, Karamchand S, Doubell AF, Reuter H, Herbst PG. Lupus myocarditis: review of current diagnostic modalities and their application in clinical practice. Rheumatology (Oxford). 2023;62(3):523\u201334.","DOI":"10.1093\/rheumatology\/keac409"},{"issue":"4","key":"1504_CR18","first-page":"1","volume":"3","author":"M Essouma","year":"2024","unstructured":"Essouma M, Noubiap JJ. Lupus and other autoimmune diseases: Epidemiology in the population of African ancestry and diagnostic and management challenges in Africa. J Allergy Clin Immunology: Global Elsevier B V. 2024;3(4):1\u201314.","journal-title":"J Allergy Clin Immunology: Global Elsevier B V"},{"issue":"3","key":"1504_CR19","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1177\/096120339400300306","volume":"3","author":"M Evans","year":"1994","unstructured":"Evans M, Abdou N. Anti-Interleukin-6 and Soluble Interleukin-6 Receptor in Systemic Lupus Erythematosus. Lupus. 1994;3(3):161\u20136.","journal-title":"Lupus"},{"issue":"1","key":"1504_CR20","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/rmv.445","volume":"15","author":"DL Fairweather","year":"2005","unstructured":"Fairweather DL, Frisancho-Kiss S, Rose NR. Viruses as adjuvants for autoimmunity: Evidence from Coxsackievirus-induced myocarditis. Rev Med Virol. 2005;15(1):17\u201327.","journal-title":"Rev Med Virol"},{"issue":"1","key":"1504_CR21","first-page":"62","volume":"74","author":"JA Fontes","year":"2015","unstructured":"Fontes JA, Rose NR, \u010cih\u00e1kov\u00e1 D. The varying faces of IL-6: From cardiac protection to cardiac failure. Cytokine Acad Press. 2015;74(1):62\u20138.","journal-title":"Cytokine Acad Press"},{"key":"1504_CR22","first-page":"1","volume":"6","author":"J Godsell","year":"2016","unstructured":"Godsell J, Rudloff I, Kandane-Rathnayake R, Hoi A, Nold MF, Morand EF, et al. Clinical associations of IL-10 and IL-37 in systemic lupus erythematosus. Sci Rep Nat Publishing Group. 2016;6:1\u201310.","journal-title":"Sci Rep Nat Publishing Group"},{"key":"1504_CR23","doi-asserted-by":"crossref","unstructured":"Guo Q, Wu LM, Wang Z, Shen JY, Su X, Wang CQ, et al. Early Detection of Silent Myocardial Impairment in Drug-Naive Patients With New-Onset Systemic Lupus Erythematosus: A Three-Center Prospective Study. Arthritis and Rheumatology. John Wiley and Sons Inc. 2018;70:2014\u201324.","DOI":"10.1002\/art.40671"},{"issue":"22","key":"1504_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1532-429X-14-22","volume":"14","author":"DO H-Ici","year":"2012","unstructured":"H-Ici DO, Ridgway JP, Kuehne T, Berger F, Plein S, Sivananthan M, et al. Cardiovascular magnetic resonance of myocardial edema using a short inversion time inversion recovery (STIR) black-blood technique: Diagnostic accuracy of visual and semi-quantitative assessment. J Cardiovasc Magn Reson. 2012;14(22):1\u20139.","journal-title":"J Cardiovasc Magn Reson"},{"key":"1504_CR24","doi-asserted-by":"crossref","unstructured":"Hassan K, Kyriakakis C, Joubert L, Van Zyl G, Zaharie D, Doubell A et al. Routine use of fluoroscopic and real-time transthoracic echocardiographic guidance to ensure safety of right ventricular endomyocardial biopsy in a low-volume center. Catheterization and Cardiovascular Interventions. John Wiley and Sons Inc. 2022;99(5):1563\u201371.","DOI":"10.1002\/ccd.30070"},{"key":"1504_CR26","first-page":"185","volume":"14","author":"N Kikuchi","year":"2021","unstructured":"Kikuchi N, Watanabe E, Nagao M, Yoshizawa S, Kobashigawa T, Hagiwara N. Acute Myocarditis Complicating Systemic Lupus Erythematosus: Detection and Evolution of Transmural Spiral Late Gadolinium Enhancement on Cardiac Magnetic Resonance Imaging. Circ Cardiovasc Imaging Lippincott Williams Wilkins. 2021;14:185\u20139.","journal-title":"Circ Cardiovasc Imaging Lippincott Williams Wilkins"},{"issue":"91","key":"1504_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1532-429X-15-91","volume":"15","author":"CM Kramer","year":"2013","unstructured":"Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E. Standardized cardiovascular magnetic resonance (CMR) protocols 2013 update. J Cardiovasc Magn Reson. 2013;15(91):1\u201310.","journal-title":"J Cardiovasc Magn Reson"},{"issue":"2","key":"1504_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1161\/CIRCRESAHA.108.188243","volume":"104","author":"P Krishnamurthy","year":"2009","unstructured":"Krishnamurthy P, Rajasingh J, Lambers E, Qin G, Losordo DW, Kishore R. IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR. Circ Res. 2009;104(2):9\u201318.","journal-title":"Circ Res"},{"issue":"7","key":"1504_CR29","first-page":"1307","volume":"35","author":"A Kuryliszyn-Moskal","year":"2008","unstructured":"Kuryliszyn-Moskal A, Klimiuk PA, Ciolkiewicz M, Sierakowski S. Clinical significance of selected endothelial activation markers in patients with systemic lupus erythematosus. J Rheumatol [Internet]. 2008;35(7):1307\u201320. Available from: www.jrheum.org.","journal-title":"J Rheumatol [Internet]"},{"issue":"1","key":"1504_CR30","doi-asserted-by":"publisher","first-page":"15970","DOI":"10.1038\/s41598-023-43350-0","volume":"13","author":"R Li","year":"2023","unstructured":"Li R, Yang C, Tang YY, Wang DC, Xu WD, Huang AF. Association between endothelin-1 and systemic lupus erythematosus: insights from a case\u2013control study. Sci Rep Nat Res. 2023;13(1):15970.","journal-title":"Sci Rep Nat Res"},{"issue":"12","key":"1504_CR31","first-page":"1","volume":"52","author":"DOC Lino","year":"2019","unstructured":"Lino DOC, Freitas IA, Meneses GC, Martins AMC, Daher EF, Rocha JHC, et al. Interleukin-6 and adhesion molecules VCAM-1 and ICAM-1 as biomarkers of post-acute myocardial infarction heart failure. Brazilian J Med Biol Res Associacao Brasileira de Divulgacao Cient. 2019;52(12):1\u20136.","journal-title":"Brazilian J Med Biol Res Associacao Brasileira de Divulgacao Cient"},{"key":"1504_CR33","doi-asserted-by":"crossref","unstructured":"Luo S, Dou WQ, Schoepf UJ, Varga-Szemes A, Pridgen WT, Zhang LJ. Cardiovascular magnetic resonance imaging in myocardial involvement of systemic lupus erythematosus. Trends Cardiovasc. Med. Elsevier Inc. 2023;33(6):346\u201354.","DOI":"10.1016\/j.tcm.2022.02.002"},{"issue":"3","key":"1504_CR34","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s13770-023-00525-0","volume":"20","author":"S Moon","year":"2023","unstructured":"Moon S, Hong J, Go S, Kim BS. Immunomodulation for Tissue Repair and Regeneration. Tissue Eng Regen Med Korean Tissue Eng Regenerative Med Soc. 2023;20(3):389\u2013409.","journal-title":"Tissue Eng Regen Med Korean Tissue Eng Regenerative Med Soc"},{"issue":"8","key":"1504_CR35","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1191\/0961203304lu1047cr","volume":"13","author":"F Moosig","year":"2004","unstructured":"Moosig F, Zeuner R, Renk C, Schr\u00f6der JO. IL-1RA in refractory systemic lupus erythematosus. Lupus. 2004;13(8):605\u20136.","journal-title":"Lupus"},{"key":"1504_CR36","doi-asserted-by":"crossref","unstructured":"Moudgil KD, Choubey D. Cytokines in autoimmunity: Role in induction, regulation, and treatment. Journal of Interferon and Cytokine Research. Mary Ann Liebert Inc. 2011;31(10):695\u2013703.","DOI":"10.1089\/jir.2011.0065"},{"issue":"11","key":"1504_CR37","first-page":"1","volume":"133","author":"T Nakao","year":"2023","unstructured":"Nakao T, Libby P. IL-6 helps weave the inflammatory web during acute coronary syndromes. J Clin Invest Am Soc Clin Invest. 2023;133(11):1\u20133.","journal-title":"J Clin Invest Am Soc Clin Invest"},{"key":"1504_CR38","doi-asserted-by":"crossref","unstructured":"Narasimhulu CA, Singla DK. The role of bone morphogenetic protein 7 (BMP-7) in inflammation in heart diseases. Cells. Multidisciplinary Digital Publishing Institute (MDPI). 2020;9(2):1\u201330.","DOI":"10.3390\/cells9020280"},{"key":"1504_CR39","doi-asserted-by":"publisher","unstructured":"Ollewagen T, Myburgh KH, van de Vyver M, Smith C. Rheumatoid cachexia: the underappreciated role of myoblast, macrophage and fibroblast interplay in the skeletal muscle niche. J. Biomed. Sci. BioMed Central; 2021;28(1):1\u201316. Available from: https:\/\/doi.org\/10.1186\/s12929-021-00714-w","DOI":"10.1186\/s12929-021-00714-w"},{"key":"1504_CR40","first-page":"1","volume":"2022","author":"T Ollewagen","year":"2022","unstructured":"Ollewagen T, Tarr GS, Myburgh KH, Reuter H, Smith C. Therapeutic Benefit in Rheumatoid Cachexia Illustrated Using a Novel Primary Human Triple Cell Coculture Model. Int J Inflam. 2022;2022:1\u201314.","journal-title":"Int J Inflam"},{"issue":"1","key":"1504_CR41","first-page":"5","volume":"52","author":"L Panchal","year":"2006","unstructured":"Panchal L, Divate S, Vaideeswar P, Pandit S. Cardiovascular involvement in systemic lupus erythematosus: An autopsy study of 27 patients in India. J Postgrad Med. 2006;52(1):5\u201310.","journal-title":"J Postgrad Med"},{"key":"1504_CR42","first-page":"715","volume":"33","author":"CN Pisoni","year":"2015","unstructured":"Pisoni CN, Reina S, Arakaki D, Eimon A, Carrizo C, Borda E, et al. Elevated IL-1\u03b2 levels in anti-Ro\/SSA connective tissue diseases patients with prolonged corrected QTc interval IL-1\u03b2, anti-Ro\/SSA antibodies and prolonged QTc \/ C.N. Pisoni et al. Clin Exp Rheumatol. 2015;33:715\u201320.","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"1504_CR43","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1177\/0961203310367658","volume":"19","author":"C Pomara","year":"2010","unstructured":"Pomara C, Neri M, Bello S, Pennella A, Turillazzi E, Fineschi V. C3a, TNF-\u03b1 and interleukin myocardial expression in a case of fatal sudden cardiac failure during clinic reactivation of systemic lupus erythematosus. Lupus. 2010;19(10):1246\u20139.","journal-title":"Lupus"},{"key":"1504_CR44","doi-asserted-by":"crossref","unstructured":"Reich D, Patterson N, Ramesh V, De Jager PL, McDonald GJ, Tandon A et al. Admixture mapping of an allele affecting interleukin 6 soluble receptor and interleukin 6 levels. Am. J. Hum. Genet. University of Chicago Press. 2007;80(4):716\u201326.","DOI":"10.1086\/513206"},{"issue":"1","key":"1504_CR45","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12968-021-00819-z","volume":"24","author":"PPS Robbertse","year":"2022","unstructured":"Robbertse PPS, Doubell AF, Lombard CJ, Talle MA, Herbst PG. Evolution of myocardial oedema and fibrosis in HIV infected persons after the initiation of antiretroviral therapy: a prospective cardiovascular magnetic resonance study. J Cardiovasc Magn Reson BioMed Cent Ltd. 2022;24(1):2\u201315.","journal-title":"J Cardiovasc Magn Reson BioMed Cent Ltd"},{"key":"1504_CR46","first-page":"1708","volume":"40","author":"E Rzeszotarska","year":"2022","unstructured":"Rzeszotarska E, Sowinska A, Stypinska B, Lutkowska A, Felis-Giemza A, Olesinska M, et al. IL-1\u03b2, IL-10 and TNF-\u03b1 polymorphisms may affect systemic lupus erythematosus risk and phenotype TNF-\u03b1, IL-1\u03b2, and IL-10 polymorphisms in SLE \/ E. Rzeszotarska et al. Clin Exp Rheumatol. 2022;40:1708\u201317.","journal-title":"Clin Exp Rheumatol"},{"key":"1504_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/604892","volume":"2012","author":"J Schwartzman-Morris","year":"2012","unstructured":"Schwartzman-Morris J, Putterman C. Gender differences in the pathogenesis and outcome of lupus and of lupus nephritis. Clin Dev Immunol. 2012;2012:1\u20139.","journal-title":"Clin Dev Immunol"},{"key":"1504_CR48","doi-asserted-by":"crossref","unstructured":"Seferovi\u0107 PM, Tsutsui H, McNamara DM, Risti\u0107 AD, Basso C, Bozkurt B et al. Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy. Eur. J. Heart Fail. John Wiley and Sons Ltd. 2021;23(6):854\u201371.","DOI":"10.1002\/ejhf.2190"},{"key":"1504_CR49","first-page":"1","volume":"11","author":"M Sharifi-Rad","year":"2020","unstructured":"Sharifi-Rad M, Anil Kumar NV, Zucca P, Varoni EM, Dini L, Panzarini E, et al. Lifestyle, Oxidative Stress, and Antioxidants: Back and Forth in the Pathophysiology of Chronic Diseases. Front Physiol Front Media S A. 2020;11:1\u201321.","journal-title":"Front Physiol Front Media S A"},{"key":"1504_CR50","doi-asserted-by":"crossref","unstructured":"Shortanbayev A, Bizhigitova B, Tarabayeva A, Nurmuchanbetova A. Features of Cytokine Profile in Different Age Groups. Cent. Asian J. Glob. Health. University Library System, University of Pittsburgh. 2014;3:173.","DOI":"10.5195\/cajgh.2014.173"},{"issue":"17","key":"1504_CR51","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1001\/jama.2024.2315","volume":"331","author":"CH Siegel","year":"2024","unstructured":"Siegel CH, Sammaritano LR. Systemic Lupus Erythematosus: A Review. JAMA Am Med Association. 2024;331(17):1480\u201391.","journal-title":"JAMA Am Med Association"},{"issue":"11","key":"1504_CR52","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1152\/ajpcell.00011.2009","volume":"298","author":"CC Silliman","year":"2010","unstructured":"Silliman CC, Kelher MR, Gamboni-Robertson F, Hamiel C, England KM, Dinarello CA, et al. Tumor necrosis factor-causes release of cytosolic interleukin-18 from human neutrophils. Am J Physiol Cell Physiol [Internet]. 2010;298(11):714\u201324. Available from: www.ajpcell.org.","journal-title":"Am J Physiol Cell Physiol [Internet]"},{"issue":"1","key":"1504_CR53","first-page":"2","volume":"11","author":"DK Singla","year":"2016","unstructured":"Singla DK, Singla R, Wang J. BMP-7 treatment increases M2 macrophage differentiation and reduces inflammation and plaque formation in Apo E-\/-Mice. PLoS One Public Libr Sci. 2016;11(1):2\u201317.","journal-title":"PLoS One Public Libr Sci"},{"key":"1504_CR54","doi-asserted-by":"publisher","unstructured":"Smith C, du Toit R, Ollewagen T. Potential of bone morphogenetic protein-7 in treatment of lupus nephritis: addressing the hurdles to implementation. Inflammopharmacology [Internet]. Springer International Publishing; 2023;31(5):2161\u201372. Available from: https:\/\/doi.org\/10.1007\/s10787-023-01321-x","DOI":"10.1007\/s10787-023-01321-x"},{"key":"1504_CR55","doi-asserted-by":"crossref","unstructured":"Tanwani J, Tselios K, Gladman DD, Su J, Urowitz MB. Lupus myocarditis: a single center experience and a comparative analysis of observational cohort studies. Lupus. SAGE Publications Ltd. 2018;27(8):1296\u2013302.","DOI":"10.1177\/0961203318770018"},{"issue":"1","key":"1504_CR56","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3899\/jrheum.160493","volume":"44","author":"G Thomas","year":"2017","unstructured":"Thomas G, Aubart FC, Chiche L, Haroche J, Hie M, Hervier B, et al. Lupus myocarditis: Initial presentation and longterm outcomes in a multicentric series of 29 patients. J Rheumatol J Rheumatol. 2017;44(1):24\u201332.","journal-title":"J Rheumatol J Rheumatol"},{"issue":"1","key":"1504_CR57","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1177\/0961203313509296","volume":"23","author":"N Tiffin","year":"2014","unstructured":"Tiffin N, Hodkinson B, Okpechi I. Lupus in Africa: Can we dispel the myths and face the challenges? Lupus. 2014;23(1):102\u201311.","journal-title":"Lupus"},{"issue":"2","key":"1504_CR61","first-page":"129","volume":"32","author":"WYI Tseng","year":"2016","unstructured":"Tseng WYI, Su MYM, Tseng YHE. Introduction to cardiovascular magnetic resonance: Technical principles and clinical applications. Acta Cardiol Sin Repub China Soc Cardiol. 2016;32(2):129\u201344.","journal-title":"Acta Cardiol Sin Repub China Soc Cardiol"},{"key":"1504_CR32","doi-asserted-by":"crossref","unstructured":"Van Linthout S, Tsch\u00f6pe C. Inflammation \u2013 Cause or Consequence of Heart Failure or Both? Curr. Heart Fail. Rep. Current Science Inc. 2017:251\u201365.","DOI":"10.1007\/s11897-017-0337-9"},{"issue":"7","key":"1504_CR62","first-page":"e63875","volume":"16","author":"S Verma","year":"2024","unstructured":"Verma S, Shah S, Nanda R, Meher J, Rathore V, Patel S, et al. Exploring the Role of Th10 Cells and IL-10 in Systemic Lupus Erythematosus. Cureus Springer Sci Bus Media LLC. 2024;16(7):e63875.","journal-title":"Cureus Springer Sci Bus Media LLC"},{"key":"1504_CR63","doi-asserted-by":"crossref","unstructured":"Vyas V, Vyas V, Sharma A, Kumar PA. Cardiac Involvement in Systemic Lupus Erythematosus. Rev. Cardiovasc. Med. IMR Press Limited. 2025.","DOI":"10.31083\/RCM42760"},{"key":"1504_CR64","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0002-9343(02)01223-8","volume":"113","author":"M Wijetunga","year":"2002","unstructured":"Wijetunga M, Rockson S. Myocarditis in Systemic Lupus Erythematosus. Am J Med. 2002;113:419\u201323.","journal-title":"Am J Med"},{"key":"1504_CR65","doi-asserted-by":"crossref","unstructured":"Wu DH, Hatzopoulos AK. Bone morphogenetic protein signaling in inflammation. Exp. Biol. Med. SAGE Publications Inc. 2019:147\u201356.","DOI":"10.1177\/1535370219828694"},{"key":"1504_CR66","doi-asserted-by":"crossref","unstructured":"Yo JH, Barbour TD, Nicholls K. Management of refractory lupus nephritis: Challenges and solutions. Volume 11. Open Access Rheumatol. Dove Medical Press Ltd. 2019:179\u201388.","DOI":"10.2147\/OARRR.S166303"}],"container-title":["Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s10020-026-01504-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-026-01504-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s10020-026-01504-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T23:17:57Z","timestamp":1786663077000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s10020-026-01504-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1504"],"URL":"https:\/\/doi.org\/10.1186\/s10020-026-01504-6","relation":{},"ISSN":["1528-3658"],"issn-type":[{"value":"1528-3658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"12 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Protocols were ethically approved by the Stellenbosch University Human Research Ethics Committee (HREC2-2020-13147) and included gaining informed consent from all participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"127"}}